OUP Management Co., LLC
- SEC CIK
- 0001880124
- Latest filing
- Nov 9, 2023
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed Apr 24, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 14
- 0 vs. Q4 2022
- Portfolio value
- $50.1M
- −$11.1M (−18.2%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| JBIOJade Biosciences, Inc. | COM | 603,762 | $12.2M | 24.3% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,937,615 | $11.3M | 22.6% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 268,346 | $7.69M | 15.3% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 989,232 | $4.72M | 9.4% | 00.0% | Unchanged | History |
| CYTCyteir Therapeutics, Inc. | COM | 2,459,572 | $4.48M | 8.9% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 389,668 | $2.40M | 4.8% | −787,929−66.9% | Reduced | History |
| VORVor Biopharma Inc. | COM | 374,714 | $2.02M | 4.0% | 00.0% | Unchanged | History |
| PRMEPrime Medicine, Inc. | COM | 121,255 | $1.49M | 3.0% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 862,543 | $1.20M | 2.4% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 406,308 | $995.5K | 2.0% | 00.0% | Unchanged | History |
| DTILPrecision Biosciences Inc | COM | 1,123,913 | $847.0K | 1.7% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 1,025,697 | $361.8K | 0.7% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 249,070 | $361.2K | 0.7% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 64,000 | $65.9K | 0.1% | 00.0% | Unchanged | History |